AI-powered
podcast player
Listen to all your favourite podcasts with AI-powered features
Accelerating Clinical Trials for Mitochondrial Rejuvenation
This chapter explores the potential of a mitochondrial rejuvenation medication achieving breakthrough status, which could expedite its clinical trial approval. It also examines the competitive landscape, including contributions from Japanese scientists and major pharmaceutical companies, alongside the challenges of high drug development costs in America.